Inventor

ALKON DANIEL L

US52 patents

⚠️ This page may combine multiple inventors who share the name “ALKON DANIEL L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ALKON DANIEL L

US HEALTH

Top down preprocessor for a machine vision system

Diagnostic method for Alzheimer&#39;s disease

Diagnostic test for alzheimers disease

Cell tests for Alzheimer&#39;s disease

Diagnostic tests for alzheimers disease

Controlling attention and memory by altering neuronal carbonic anhydrase activity

Cell tests for alzheimer&#39;s disease

BRNI NEUROSCIENCES INST

Treatment of depressive disorders

Methods for Alzheimer&#39;s Disease treatment and cognitive enhancement

Alzheimer&#39;s disease-specific alterations of the Erk1/Erk2 phosphorylation ratio

Esters of DCPLA and methods of treatment using the same

Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier

Alzheimer&#39;s disease diagnosis based on mitogen-activated protein kinase phosphorylation

Synergistic enhancement of cognitive ability

COGNITIVE RES ENTERPRISES INC

PKC-activating compounds for the treatment of neurodegenerative diseases

Dosing regimens of PKC activators

PKC-activating compounds for the treatment of neurodegenerative diseases

Dosing regimens of PKC activators

PKC-activating compounds for the treatment of neurodegenerative diseases

Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases

PKC activators and combinations thereof

BLANCHETTE ROCKEFELLER NEUROSCIENCES INST

Methods for Alzheimer&#39;s disease treatment and cognitive enhancement

Alzheimer&#39;s disease-specific alterations of the ERK1/ERK2 phosphorylation ratio-alzheimer&#39;s disease-specific molecular biomarkers (ADSMB)

Methods for Alzheimer&#39;S disease treatment and cognitive enhancement

Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases

PKC activators and anticoagulant in regimen for treating stroke

ALKON DANIEL L

Method for the removal of splinters

Protein synthesis required for long-term memory is induced by PKC activation on days preceding associative learning

Compositions and methods to treat Niemann-Pick disease

PKC activators and anticoagulant in regimen for treating stroke

US ARMY

Dynamically stable associative learning neural network system

Dynamically stable associative learning neural system

Artificial network for temporal sequence processing

USA

Dynamically stable associative learning neural system with one fixed weight

Neural network with weight adjustment based on prior history of input signals

NELSON THOMAS J

PKC-activating compounds for the treatment of neurodegenerative diseases

PKC-activating compounds for the treatment of neurodegenerative diseases

SYNAPTOGENIX INC

Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases

PKC-activating compounds for the treatment of neurodegenerative diseases

NeuroDiagnostics LLC

Lymphocyte-based morphometric test for alzheimer&#39;s disease

Lymphocyte-based morphometric test for alzheimer&#39;s disease

ENVIRONMENTAL RES INST

Dynamically stable associative learning neural network system

CHIRILA FLORIN VALENTIN

Fibroblast growth patterns for diagnosis of Alzheimer&#39;s disease

NEUROTROPE BIOSCIENCE INC

Methods for inducing synaptogenesis with synaptic growth factor activating compounds

ZHAO WEI-QIN

Alzheimer&#39;s disease diagnosis based on mitogen-activated protein kinase phosphorylation

SUN MIAO-KUN

Treatment of cognitive disorders associated with abnormal dendritic spines using PKC activators

CHIRILA FLORIN V

Peripheral diagnostic methods for screening Alzheimer&#39;s disease using beta amyloid and intercellular communication

UNIV WEST VIRGINIA

Peripheral diagnostic methods for screening Alzheimer&#39;s disease using beta amyloid and intercellular communication

BLANCHETTE ROCKEFELLER NEUROSCIENCES INST INC

Compositions and methods to treat niemann-pick disease

BLANCHETTE ROCKEFELLER NEUROSCIENCE INST

Treatment of depressive disorders

Diagnostic method for Alzheimer's disease

Cell tests for Alzheimer's disease

Cell tests for alzheimer's disease

Methods for Alzheimer's Disease treatment and cognitive enhancement

Alzheimer's disease-specific alterations of the Erk1/Erk2 phosphorylation ratio

Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation

Methods for Alzheimer's disease treatment and cognitive enhancement

Alzheimer's disease-specific alterations of the ERK1/ERK2 phosphorylation ratio-alzheimer's disease-specific molecular biomarkers (ADSMB)

Methods for Alzheimer'S disease treatment and cognitive enhancement

Lymphocyte-based morphometric test for alzheimer's disease

Lymphocyte-based morphometric test for alzheimer's disease

Fibroblast growth patterns for diagnosis of Alzheimer's disease

Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation

Peripheral diagnostic methods for screening Alzheimer's disease using beta amyloid and intercellular communication

Peripheral diagnostic methods for screening Alzheimer's disease using beta amyloid and intercellular communication